Bayer Aktiengesellschaft (ETR:BAYN) Trading Down 1.5% - Time to Sell?

Key Points

• Bayer Aktiengesellschaft's stock dropped by 1.5%, with shares trading at €27.44 ($31.90) after a mid-day low of €27.26 ($31.69).
• The company's market capitalization stands at $27.70 billion, and it has a P/E ratio of -31.47.
• Bayer operates in various segments including Pharmaceuticals, Consumer Health, and Crop Science, focusing on innovative therapeutic products and solutions.

Bayer Aktiengesellschaft (ETR:BAYN - ) shares dropped 1.5% during mid-day trading on Wednesday . The stock traded as low as €27.26 ($31.69) and last traded at €27.44 ($31.90). Approximately 1,849,640 shares were traded during mid-day trading, The stock had previously closed at €27.86 ($32.40).

Bayer Aktiengesellschaft Price Performance

The company has a 50 day simple moving average of €27.35 and a 200-day simple moving average of €24.77. The stock has a market capitalization of $27.70 billion, a P/E ratio of -31.47, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.